The Foresite Capital is a for-profit health care company that offers its services to both public and private medical centers. It is based in San Francisco. Foresite Capital has directly invested in Mindstrong Health along with others like the Optum Ventures, One Mind Brain Health Impact Fund, and ARCH Venture Partners.
In a report by Patient Daily, the drive fund will help in the diagnosis, treatment, and management of Neuropsychiatric disorders as Jim Tananbaum, the CEO of Foresite Capital puts it. The Mindstrong Technology uses a smart phone app that objectively measures the cognitive health disorders hence prompt care given to the ailing person. Paul Dagun, the Founder, and CEO of Mindstrong Health say the system will improve the mental disorder management. For more details visit Bloomberg
Mindstrong Health boasts about its innovative professionals who are experienced, have unquestionable leadership capabilities and have a clear vision and target. From the pre-trial clinical test conducted, the community would benefit immensely if the organization was to function optimally. Dr. Tom Insel, the Mindstrong Health along with Jim sees this platform where modernity and health care interplay for the benefit of all. The platform operates like the human brain has high resolution and is feed with information to tell of the mental disorders that relate to its functioning, speed, and memory. Check out LinkedIn to know more.
About Jim Tananbaum
Jim Tanabaum is the founding CEO of the Foresite Capital, a leading company in the health care services and support. With his impressive experience in the pharmaceutical industry where he has previously worked for, this was a well-informed venture to take his medical career upwards to continue serving the people. He is an accomplished scholar having gone through the Yale University for an engineering degree, then a medical degree from the Harvard Medical School and an MBA from the Harvard Business School.
He has worked with some great pharmaceutical companies such as the Geltex and the Theravance before co-founding the Foresite Capital. Jim has played the advisory role on the boards of the Yale School of Engineering, Harvard MIT-HST Program, Amerigroup, Tarsa Therapeutics, Amira Pharmaceuticals and Jazz Pharmaceuticals. Through him over 21 healthcare companies have benefited from Foresite Capital services.
Click here: https://www.facebook.com/public/Jim-Tananbaum